News

Press ReleaseKing's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumours
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Press Release: Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative MedicinePress Release: Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative MedicineRegulatory news - January 2018Regulatory news - January 2018January newsletterJanuary newsletterRexgenero secures Innovate UK grantRexgenero secures Innovate UK grantPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityPress release: CGT Catapult announces vector production agreement with AdaptimmunePress release: CGT Catapult announces vector production agreement with AdaptimmuneCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of WellnessCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of WellnessRegulatory news - December 2017Regulatory news - December 2017December newsletterDecember newsletterGrowth in UK cell and gene therapy industry continues for fifth year runningGrowth in UK cell and gene therapy industry continues for fifth year running